Bide Pharmatech Co., Ltd. (SHA:688073)

China · Delayed Price · Currency is CNY

61.93

+3.65 (6.26%)

At close: Feb 3, 2026

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Molecular Building Blocks Heterocyclic Compounds	474.77M
Molecular Building Blocks Heterocyclic Compounds Growth	0.61%
Molecular Building Blocks Benzene Ring Compounds	272.23M
Molecular Building Blocks Benzene Ring Compounds Growth	-7.98%
Molecular Building Blocks Aliphatic Compounds	189.04M
Molecular Building Blocks Aliphatic Compounds Growth	6.39%
Catalysts and Ligands	115.47M
Catalysts and Ligands Growth	9.30%
Active Small Molecule Compounds	50.48M
Active Small Molecule Compounds Growth	23.86%
Other	14.10K
Other Growth	-58.71%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
International	615.97M
International Growth	10.58%
China	486.04M
China Growth	-9.12%